Cardiovascular effects after epidural injection of xylazine in isoflurane-anesthetized dogs.
The cardiovascular effects following epidural injection of xylazine or isotonic saline during isoflurane anesthesia were assessed in six healthy dogs. Dogs were anesthetized with isoflurane in O2 and maintained at 2.0% end-tidal concentration. Ventilation was controlled to maintain PaCO2 at 35 to 45 mm Hg. The dorsal pedal artery was cannulated for measurement of arterial blood pressure (AP)(systolic AP, mean AP, diastolic AP) and for blood sample collection. Arterial pH and blood gas tensions (PaO2 and PaCO2) were determined. Cardiac output was measured by thermodilution. The electrocardiogram (ECG), heart rate (HR), core body temperature, central venous pressure (CVP), mean pulmonary AP, and end-tidal isoflurane concentration (ETISO) and CO2 tension (ETCO2) were monitored. Systemic vascular resistance (SVR), arterial HCO2 concentration, base balance, and cardiac index (CI) were calculated. After baseline measurements were taken, either xylazine (0.2 mg/kg) in 5 mL isotonic saline or 5 mL of isotonic saline was injected into the lumbosacral epidural space. Data were then recorded at 5, 15, 30, 45, 60, 75, 90, 105, and 120 minutes after epidural injection. Data were analyzed by two-way analysis of variance (ANOVA) for repeated measures. When significant differences were encountered, mean values were compared using Bonferroni's test. The level of significance was set at P < .05. Mean values for diastolic AP decreased at 90 and 120 minutes compared with the mean value at 15 minutes after epidural injection of xylazine. No differences were detected at any time or between treatments for HR, systolic AP, mean AP, CVP, CI, SVR, mean pulmonary AP, temperature, ETCO2, ETISO, arterial pH, PaCO2, PaO2, plasma bicarbonate concentration, or base balance.(ABSTRACT TRUNCATED AT 250 WORDS)
Greene
S A
SA
Department of Veterinary Clinical Sciences, Washington State University, Pullman 99164, USA.
Keegan
R D
RD
Weil
A B
AB
D000704:Analysis of Variance; D000769:Anesthesia, Inhalation / Q000662:veterinary; D000818:Animals; D001831:Body Temperature / Q000187:drug effects / Q000502:physiology; D002320:Cardiovascular Physiological Phenomena; D002319:Cardiovascular System / Q000187:drug effects; D004285:Dogs / Q000502:physiology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006863:Hydrogen-Ion Concentration; D007268:Injections, Epidural / Q000662:veterinary; D007530:Isoflurane / Q000008:administration & dosage; D007552:Isotonic Solutions; D008297:Male; D012965:Sodium Chloride / Q000008:administration & dosage; D014991:Xylazine / Q000008:administration & dosage*
D007552:Isotonic Solutions; D014991:Xylazine; D012965:Sodium Chloride; D007530:Isoflurane